BioMerieux SA (EYWN.MU) reported earnings for full year that Drops, from the same period last year
The company's bottom line totaled EUR397.5 million, or EUR3.34 per share. This compares with EUR432.2 million, or EUR3.64 per share, last year.
Excluding items, BioMerieux SA reported adjusted earnings of EUR552.0 million or EUR4.64 per share for the period.
The company's revenue for the period rose 2.3% to EUR4.069 billion from EUR3.979 billion last year.
BioMerieux SA earnings at a glance (GAAP) :
-Earnings: EUR397.5 Mln. vs. EUR432.2 Mln. last year.-EPS: EUR3.34 vs. EUR3.64 last year.-Revenue: EUR4.069 Bln vs. EUR3.979 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.